ANEBULO PHARMACEUTICALS INC

Historical 13F Holders

Symbol
ANEB
CUSIP
034569103
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 034569103 since 12/18/2024, largest first.

Filer % of Class Filed
Aron R. English 13D/A
51.1% 2/27/2025
Event 2/24/2025
Nantahala Capital Management, LLC 13G/A
8.5% 2/13/2026
Event 12/31/2025
Mangrove Partners IM, LLC 13G
6.2% 3/17/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q4 19 22.2 M $91.6 M
2025 Q3 22 22.2 M $55.6 M
2025 Q2 19 22.6 M $32.5 M
2025 Q1 19 22.6 M $29.4 M
2024 Q4 16 22.6 M $37.3 M
2024 Q3 15 7.34 M $14.2 M
2024 Q2 17 8.22 M $22.4 M
2024 Q1 19 8.10 M $23.3 M
2023 Q4 17 8.19 M $19.8 M
2023 Q3 13 7.05 M $21.6 M
2023 Q2 13 7.03 M $16.5 M
2023 Q1 11 6.84 M $19.8 M
2022 Q4 13 7.05 M $17.1 M
2022 Q3 12 6.84 M $19.2 M
2022 Q2 10 4.68 M $24.3 M
2022 Q1 11 4.19 M $29.5 M
2021 Q4 11 4.19 M $25.8 M
2021 Q3 10 4.18 M $27.5 M
2021 Q2 10 4.20 M $28.7 M